Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

<h4>Background</h4>Although genotypic resistance testing (GRT) is recommended to guide combination antiretroviral therapy (cART), funding and/or facilities to perform GRT may not be available in low to middle income countries. Since treatment history (TH) impacts response to subsequent t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mattia C F Prosperi, Michal Rosen-Zvi, André Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, Peter Sloot, David A van de Vijver, Anne-Mieke Vandamme, Anders Sönnerborg, EuResist study group, Virolab study group
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2010
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/133459cb09394a9d94e80aa53ce3dc4f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/133459cb09394a9d94e80aa53ce3dc4f

Documents similaires